Sleeker Incyte flirts with drug discovery
Article Abstract:
Incyte Genomics Inc. will close its custom genomics and microassay unit, laying off 30 percent of its staff. The company is evidently considering focusing on a gene-database subscription service, and might leverage its existing patents.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
Labor force information, On-Line Information Services, Organizational history, Personnel administration, Information retrieval services, Medical Database Vendors, Health care information services, Incyte Genomics Inc., IPI
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
US stem cell policy comes under fire
Article Abstract:
George W. Bush's decision to allow federal funding for stem cell research from 64 cell lines will hinder developments in the field ,according to critics.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
Government regulation (cont), Scientific Research and Development Services, Cellular Biology, General Science & Basic Research, Research, Illustration, Cytology
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Genetic engineering
Similar abstracts:
- Abstracts: GeneMedix sets sights on Southeast Asia. Approval heralds new generation of kinase inhibitors? Millennium and Aventis in unique pact
- Abstracts: In pursuit of that "killer application."(interactive kiosk operations)
- Abstracts: USDA scrutinizes GM organism regulations. US bioterrorism countermeasures research builds across a broad front
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.